Navigation Links
Scientists far from finish line in understanding anemia in female athletes
Date:11/20/2013

ANN ARBORWhen Kaitlyn Patterson's fatigue progressed to hyperventilating even during slow runs, and then forced her to quit high school distance running for the season, she knew something was very wrong.

Patterson had exercise-induced iron-deficiency anemia, a common, perplexing problem among elite female athletes, especially endurance runners. Later, as a University of Michigan sophomore, she was so interested in the topic that she applied for an undergraduate research position in the lab of Peter Bodary, U-M clinical assistant professor of movement science and health & fitness.

Patterson recently co-wrote a study challengingand perhaps putting to resta popular hypothesis on what causes exercise-induced iron-deficiency anemia.

It's another in a succession of findings from separate research groups that debunk the notion that the iron-regulating hormone hepcidin causes exercise-induced anemia. Conventional science has suggested that rigorous exercise causes hepcidin spikes that result in anemia.

"The U-M finding is significant because we want to provide physicians with the most accurate information regarding exercise-induced anemia," Bodary said.

The downside is that hepcidin isn't the anemia cure-all the scientific community had hoped.

Bodary said that physicians already do a nice job of helping athletes recover from exercise-induced anemia by providing iron supplementation and educating athletes about optimizing iron absorption. The challenge now is understanding what causes anemia in order to prevent it.

The U-M study is the first known to compare hepcidin levels in competitive college female runners against those of non-exercisers, Bodary said. About half the runners in the study had a history of anemia and about 85 percent supplemented with iron.

Researchers wanted to see if hepcidin remained high in resting athletes, which could link elevated hepcidin with exercise-induced iron-deficiency anemia. However, overall hepcidin levels in both groups were about equal, Bodary said.

Will scientists have to return to the starting line? Not necessarily. A physician familiar with Bodary's research contacted him about a female patient with long-term anemia that is hypothesized to have elevated levels of resting hepcidin. Although she didn't exercise regularly, her blood work resembled that of an athlete with the disease, Bodary said.

By analyzing the woman's blood samples, Bodary's lab hopes to learn if high hepcidin drives her anemia. Results could help scientists decode what causes anemia in both the general population of women and in elite athletes.

Meanwhile, Patterson remains healthy since her first struggles with anemia.

"I still run, and have returned to cross country skiing and have taken up cycling," she said. "I'm planning on ski racing this winter and putting together a solid triathlon season. I've been fortunate in that I responded well to iron supplementation, so I've stayed healthy since my original bout with anemia."


'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

Related medicine news :

1. LSUHSC faculty shares inside knowledge in book to develop nations research scientists
2. Renowned Scientists Join Cure Alzheimer’s Fund’s Search for Alzheimer’s Therapies
3. Scientists fingerprint single cancer cells to map cancers family tree
4. A*STAR scientists bring to light mechanism of drug for infections
5. NSF International Scientists Announce Discovery of New Bacterium, Same Family as E. coli and Klebsiella Pneumonia
6. CNIO scientists decipher how the immune system induces liver damage during hepatitis
7. A*STAR scientists uncover potential drug target to nip cancer in the bud
8. Volunteers join scientists in finding out who gets rid of cow dung
9. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
10. Leicester scientists map structure of key complex in the immune system
11. Neuroscientists determine how treatment for anxiety disorders silences fear neurons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: